Transluminal Technologies
Syracuse
About Transluminal Technologies
Transluminal Technologies develops intellectual property related to interventional cardiovascular medical devices. Its vascular closure device offers a way of reaching mechanical vascular closure that seals the arteriotomy to achieve immediate hemostasis and then absorbs over a period of days as natural healing occurs that enable patients to quickly recover after a cardiovascular surgery.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $3.0M
- Last round: Series Unknown (May 2015)
- Website: transluminal.net
- Phone: 315-476-7510
Industries & Categories
Biotechnology, Health Care, Intellectual Property, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/transluminal-technologies-2909654 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.